NAC Dosing Recommendations
For acute acetaminophen overdose, administer intravenous N-acetylcysteine at a total dose of 300 mg/kg over 21 hours using the FDA-approved 3-bag protocol, starting with a 150 mg/kg loading dose over 1 hour, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours 1.
Acute Acetaminophen Overdose
The FDA-labeled regimen is the standard of care in the United States 1:
Standard IV Protocol (3-Bag Method)
- Loading dose: 150 mg/kg IV over 1 hour
- Second dose: 50 mg/kg IV over 4 hours
- Third dose: 100 mg/kg IV over 16 hours
- Total duration: 21 hours
- Total dose: 300 mg/kg
Critical timing consideration: Administer NAC as early as possible. When started within 10 hours of ingestion, hepatotoxicity occurs in only 10% of at-risk patients, but this rises to 27% when treatment begins 10-24 hours post-ingestion 2, 3. Even patients treated 12-24 hours after ingestion show significant time-dependent reduction in morbidity and mortality 2.
When to Extend Beyond 21 Hours
Continue NAC beyond the standard 21-hour protocol if 1:
- Acetaminophen levels remain detectable after the third dose
- ALT/AST continue rising
- INR remains elevated
- Massive overdose suspected
- Concomitant ingestion of other substances
- Pre-existing liver disease
Practical guidance: Check acetaminophen level, ALT/AST, and INR after completing the maintenance dose. If any abnormality persists, continue the maintenance dose (100 mg/kg over 16 hours) and contact poison control at 1-800-222-1222 1.
Alternative Oral Regimen
While IV is preferred, oral NAC remains an option 4:
- Loading dose: 140 mg/kg PO
- Maintenance: 70 mg/kg PO every 4 hours for 17 doses
- Total duration: 72 hours
Recent evidence suggests oral NAC may be as effective as standard IV dosing, even in massive overdoses 5, though the IV route is generally preferred for reliability and tolerability.
Special Populations
Repeated supratherapeutic ingestion (RSI): The Rumack-Matthew nomogram does NOT apply 1. Base treatment decisions on:
- Actual acetaminophen serum concentration (history is unreliable)
- AST, ALT, bilirubin, INR
- Creatinine, BUN, electrolytes
Contact poison control for specific dosing guidance in RSI cases 1.
Hepatotoxicity already present: Administer NAC even if presentation is delayed beyond 24 hours 2. NAC reduces disease progression in hepatic failure regardless of ingestion timing 2.
Contrast-Induced Nephropathy Prevention
For patients at increased risk of contrast-induced nephropathy, oral NAC 600 mg twice daily (day before and day of procedure) combined with IV isotonic crystalloids is suggested, though the evidence remains equivocal 6.
Standard Prophylaxis Protocol
- Elective procedures: 600 mg PO twice daily on the day before and day of procedure 7
- Emergency procedures: 150 mg/kg IV in 500 mL normal saline over 30 minutes before contrast, followed by 50 mg/kg IV in 500 mL over 4 hours 7
Higher-Risk Scenarios
For high-volume contrast procedures (≥140 mL), consider double-dose NAC 8, 9:
- 1200 mg IV bolus before procedure
- 1200 mg PO twice daily for 48 hours after
The double-dose regimen showed superior protection with high contrast volumes, reducing nephropathy from 11% to 3.5% compared to standard dosing 8. In primary angioplasty patients, high-dose NAC reduced contrast nephropathy from 33% (placebo) to 8% and decreased in-hospital mortality from 11% to 3% 9.
Important caveat: KDIGO guidelines could not definitively recommend NAC due to conflicting trial data 6. However, given the low cost, favorable safety profile, and moderate-quality evidence showing benefit 10, NAC with hydration remains reasonable for at-risk patients.
Mucolytic Therapy
For routine mucolytic use (not covered in the provided evidence), standard dosing is typically 600-1200 mg daily in divided doses, though this indication was not addressed in the acetaminophen overdose and nephropathy-focused evidence provided.
Key Safety Considerations
Hypersensitivity reactions occur in approximately 14% of patients receiving IV NAC 3:
- Most reactions (91%) are mild: transient skin erythema or urticaria during loading dose
- Rarely require discontinuation
- Management: Temporarily stop infusion, administer antihistamines, then resume at slower rate 1
- Severe reactions: Stop immediately if hypotension, wheezing, or bronchospasm occur 1
Asthma patients: Use with extreme caution and close monitoring—one fatality from bronchospasm has been reported 1.
Dilution requirement: NAC is hyperosmolar (2600 mOsmol/L) and must be diluted in sterile water, ½ normal saline, or D5W before IV administration 1.